COMMUNIQUÉS West-GlobeNewswire

IVY Rx Claims Evaluated: 2026 Compounded GLP-1 Telehealth Program Details, Monthly Pricing Structure, Clinician Access Model, and Patient Eligibility Information
11/04/2026
New 2026 program information covers self-pay pricing tiers, HSA/FSA eligibility, compounded semaglutide and tirzepatide access, three-entity telehealth structure, and key considerations for prospective patients [...]
Mesoblast Receives IND Clearance From FDA to Directly Proceed to Registrational Trial for Approval of Ryoncil® in Duchenne Muscular Dystrophy - CORRECTION
10/04/2026
Working with Parent Project Muscular Dystrophy and the Duchenne Registry on patient identification and trial awareness efforts ~15,000 children are living with DMD in the U.S. NEW YORK, April 10, 2026 (GLOBE NEWSWIRE [...]
Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
10/04/2026
CAMBRIDGE, Mass., April 10, 2026 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a biopharmaceutical company developing a new class of genetic medicines based on editing RNA for rare and highly prevalent [...]
Pelthos Therapeutics Announces CFO Transition
10/04/2026
Senior Vice President, Finance & Accounting John M. Gay named Chief Financial Officer DURHAM, N.C., April 10, 2026 (GLOBE NEWSWIRE) -- Pelthos Therapeutics Inc. (NYSE American: PTHS), a biopharmaceutical company [...]
EssilorLuxottica: Nombre total de droits de vote et d’actions composant le capital social au 31 mars 2026
10/04/2026
Nombre total de droits de vote et d’actions composant le capital social au 31 mars 2026 (Conformément à l’article L.233-8 II du Code de Commerce et aux articles 221-1 et 223-16 du Règlement Général de l’AMF) Paris, [...]
EssilorLuxottica: First-Quarter 2026 Revenue Conference Call Invitation
10/04/2026
First-Quarter 2026 Revenue Conference Call Invitation Mr STEFANO GRASSI, Chief Financial Officer, and Mr GIORGIO IANNELLA, Head of Investor Relations, have the pleasure of inviting you to our First-Quarter 2026 Revenue [...]
Matricis.ai Launches First U.S. Clinical Pilot of EndomAI for AI-Assisted Detection of Endometriosis with SimonMed
10/04/2026
Collaboration marks the first clinical pilot of AI-assisted MRI analysis for endometriosis. Paris, France, April 10, 2026 (GLOBE NEWSWIRE) -- Matricis.ai, a healthcare technology company developing artificial [...]
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of March 31, 2026
10/04/2026
Disclosure of Share Capital and Voting Rights Outstanding as of March 31, 2026 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des [...]
EssilorLuxottica: First-Quarter 2026 Revenue Conference Call Invitation
10/04/2026
First-Quarter 2026 Revenue Conference Call Invitation Mr STEFANO GRASSI, Chief Financial Officer, and Mr GIORGIO IANNELLA, Head of Investor Relations, have the pleasure of inviting you to our First-Quarter 2026 Revenue [...]
Suja Life Announces Filing of Registration Statement for Proposed Initial Public Offering
10/04/2026
OCEANSIDE, Calif., April 10, 2026 (GLOBE NEWSWIRE) -- Suja Life, Inc. today announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (the "SEC") relating to the [...]
Humber River Health Renames Wilson Site Hennick Humber Hospital Following Transformational $50 Million Gift
10/04/2026
Landmark philanthropic investment from the Hennick Family Foundation will accelerate innovation and patient care at North America’s first fully digital hospital TORONTO, April 10, 2026 (GLOBE NEWSWIRE) -- Humber River [...]
EUROBIO SCIENTIFIC : 2025 ANNUAL RESULTS
10/04/2026
2025 ANNUAL RESULTS Annual revenue up 9% to €168 million Roll-out of the Group’s strategy: Sales of proprietary products up 20%, accounting for 35% of revenue Internationalisation: 42% of revenue generated outside [...]
EUROBIO SCIENTIFIC : RESULTAT ANNUEL 2025
10/04/2026
RESULTAT ANNUEL 2025 Progression du chiffre d’affaires annuel de 9% à 168 M€ Déploiement de la stratégie du Groupe : Ventes des produits propriétaires en hausse de 20%, à 35% du Chiffre d’affaires Internationalisation [...]
NeurAxis, Inc. Announces Preferred Stock Dividend
10/04/2026
CARMEL, Ind., April 10, 2026 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic and debilitating [...]
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Strengthening Position with AI-Driven Tech in Automated Compliance Space
10/04/2026
NEW YORK, April 10, 2026 (GLOBE NEWSWIRE) -- via AINewsWire — Oncotelic Therapeutics Inc. (OTCQB: OTLC) today announces its placement in an editorial published by AINewsWire ("AINW"), one of 75+ brands within the [...]
LifeMD® Now Offering Eli Lilly and Company’s Foundayo™ (orforglipron), a New GLP-1 Pill for Weight Management
10/04/2026
LifeMD expands its weight management program with the addition of Foundayo, offering eligible patients an oral alternative to injectable GLP-1 therapies through LillyDirect® NEW YORK, April 10, 2026 (GLOBE NEWSWIRE) -- [...]
Enovis to Host First Quarter 2026 Results Conference Call on May 7th
10/04/2026
Dallas, TX, April 10, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to [...]
Unyte Health Acquires Vital Links and Vital Sounds, Developers of Therapeutic Listening®
10/04/2026
DENVER, April 10, 2026 (GLOBE NEWSWIRE) -- Unyte Health, a leader in listening therapy interventions, is proud to announce that Vital Links and Vital Sounds have officially joined its growing family of clinical [...]
Milestone Pharmaceuticals Announces RESET-PSVT Registry to Generate Real-World Evidence on CARDAMYST™ (etripamil) Nasal Spray in Patients With PSVT
10/04/2026
Registry Study Design Presented at the Preventive Cardiovascular Nurses Association 2026 Cardiovascular Nursing Symposium MONTREAL and CHARLOTTE, N.C., April 10, 2026 (GLOBE NEWSWIRE) -- Milestone ® Pharmaceuticals Inc [...]

Pages